FIELD: medicine, pharmaceutics.
SUBSTANCE: given invention refers to new 1,3-dioxane derivatives of formula: 
wherein A, W, Ar, Ra and Rb have the values specified in the description, or to their pharmaceutical salts.
EFFECT: applying the modulators in treating a disease or a condition associated with PPAR modulation, such as diabetes, cancer, inflammation, neurodegenerative disorders and infections, and also development of based pharmaceutical compositions.
23 cl, 28 ex, 2 tbl, 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIDIABETIC OXAZOLIDINEDIONES | 2005 |
|
RU2355682C2 |
| NEW CANNABIDIOL QUINONE DERIVATIVES | 2014 |
|
RU2667504C2 |
| INDOLES WITH ANTIDIABETIC ACTIVITY | 2003 |
|
RU2328483C2 |
| NEW CANNABYHEROLE DERIVATIVES | 2015 |
|
RU2684913C2 |
| 1,3,4-OXADIAZOL-2-ONES AS PPAR-DELTA MODULATORS AND APPLICATION THEREOF | 2005 |
|
RU2375358C2 |
| ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
| 2-OXINDOLE COMPOUNDS | 2017 |
|
RU2743747C2 |
| PPARγ RECEPTOR MODULATING NOVEL COMPOUNDS AND USE THEREOF IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2401836C2 |
| DERIVATIVES OF PROPIONIC ACIDS AND THEIR USING AS hPPARs ACTIVATORS | 2003 |
|
RU2316539C2 |
| THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
